bronchodilators Flashcards
SNS on the smooth muscle does what and how
it releases adrenergic compounds onto the beta 2 adrenoreceptors of the lungs. this leads to adenylate cyclase activation as they are GPCRs this leads to cAMP activation which then acts to block smooth muscle contraction
how do the muscarinic receptors act on smooth muscle
binding to M2 causes a gene-inhibitory response which inhibits adenylate cyclase resulting in decrease in cAMP so more contraction
M3 binding leads to a pathway that increases levels of calcium within the cell directly causing increased contraction of the smooth muscle cell.
how do beta 2 agonists work
example is salbutamol. these increase cAMP in the smooth muscle cell, this results in increased PKA activity. this PKA increases conductance of Ca2+-sensitive K+ channels. this results in increased hyperpolarisation of the smooth muscle cell, resulting in smooth muscle relaxation.
PKs of salbutamol
it is a rescue inhaler as it is able to reverse bronchoconstriction, it is delivered by inhalation and has a fast onset of effect in 5-15 minutes. this is good for treating exercise-induced asthma.
what do we never use at the same time as salbutamol
beta blockers like metoprolol. as these beta blockers will block the beta 2 receptors, meaning that any bronchospasm cannot be treated by beta agonists
what are ADRs
of SABAs, tremor of skeletal muscle due to activation of B2 receptors, increased heart rate and force of contraction due to activation of beta 1s.
hypokalemia possibly causing myocardium hyperexcitability
whats the difference between LABA and SABA
LABA have a lipophilic side chain which acts to resist breakdown of the drug, increasing duration of effects.
LABAs are not rescue inhalers as their effects do take longer to kick in.
whats in symbicort
there is a ICS - budesonide
then there is formoterol which replaces need for salbutamol as it can act as a rescue inhaler and a LABA
why can we not just use a LABA
these can not provide relief during acute bronchospasm. and they do not address the underlying inflammation
why do we more want to aim to antagonise the M2 receptors
Normally the ACh released at the muscarinic receptors feedsback to inhibit itself. But if we block the M2 receptors this doesn’t occur and instead there is constant activation of the M3 receptors. Hence we want to more just antagonise the M3 receptors.
what is an example of a SAMA
– Ipratropium, these antagonise the M3 and prevent the effects of the PNS there
ADRs of SAMA and how do we get around this
we get around it through inhalation. Dry mouth, headache, GI motility disorders, urinary retention, tachycardia, palpitations. Doesn’t have CNS effects as it cannot cross the blood brain barrier.
example of a LAMA
tiotropium
what are the preferred bronchodilators for COPD
the muscarinic antagonists
what receptor do the SAMAs and LAMAs antagonise
the M3 muscarinic receptors